nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—ABCB1—Lisinopril—dilated cardiomyopathy	0.106	0.532	CbGbCtD
Eletriptan—ABCB1—Spironolactone—dilated cardiomyopathy	0.0934	0.468	CbGbCtD
Eletriptan—HTR2B—cardial valve—dilated cardiomyopathy	0.071	0.385	CbGeAlD
Eletriptan—CYP2C9—cardial valve—dilated cardiomyopathy	0.046	0.25	CbGeAlD
Eletriptan—HTR7—pulmonary artery—dilated cardiomyopathy	0.0246	0.133	CbGeAlD
Eletriptan—HTR7—sympathetic nervous system—dilated cardiomyopathy	0.0239	0.13	CbGeAlD
Eletriptan—Encainide—SCN5A—dilated cardiomyopathy	0.0181	1	CrCbGaD
Eletriptan—Breast pain—Spironolactone—dilated cardiomyopathy	0.00896	0.0224	CcSEcCtD
Eletriptan—Renal pain—Lisinopril—dilated cardiomyopathy	0.00607	0.0152	CcSEcCtD
Eletriptan—Apathy—Furosemide—dilated cardiomyopathy	0.00595	0.0149	CcSEcCtD
Eletriptan—Ear disorder—Lisinopril—dilated cardiomyopathy	0.00591	0.0148	CcSEcCtD
Eletriptan—Flat affect—Furosemide—dilated cardiomyopathy	0.0059	0.0147	CcSEcCtD
Eletriptan—Ataxia—Spironolactone—dilated cardiomyopathy	0.00533	0.0133	CcSEcCtD
Eletriptan—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00511	0.0128	CcSEcCtD
Eletriptan—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00508	0.0127	CcSEcCtD
Eletriptan—Gastritis—Spironolactone—dilated cardiomyopathy	0.00502	0.0125	CcSEcCtD
Eletriptan—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00452	0.0113	CcSEcCtD
Eletriptan—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00443	0.0111	CcSEcCtD
Eletriptan—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00437	0.0109	CcSEcCtD
Eletriptan—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00417	0.0104	CcSEcCtD
Eletriptan—Otitis media—Lisinopril—dilated cardiomyopathy	0.0041	0.0102	CcSEcCtD
Eletriptan—HTR2B—heart—dilated cardiomyopathy	0.00393	0.0213	CbGeAlD
Eletriptan—Urine output increased—Furosemide—dilated cardiomyopathy	0.00384	0.0096	CcSEcCtD
Eletriptan—Mental disability—Furosemide—dilated cardiomyopathy	0.00369	0.00921	CcSEcCtD
Eletriptan—Breast pain—Lisinopril—dilated cardiomyopathy	0.00366	0.00913	CcSEcCtD
Eletriptan—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00361	0.009	CcSEcCtD
Eletriptan—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00361	0.009	CcSEcCtD
Eletriptan—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00357	0.0089	CcSEcCtD
Eletriptan—Viral infection—Lisinopril—dilated cardiomyopathy	0.00353	0.00882	CcSEcCtD
Eletriptan—Polyuria—Furosemide—dilated cardiomyopathy	0.00352	0.00878	CcSEcCtD
Eletriptan—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00351	0.00876	CcSEcCtD
Eletriptan—Cough increased—Lisinopril—dilated cardiomyopathy	0.00349	0.0087	CcSEcCtD
Eletriptan—Alopecia—Spironolactone—dilated cardiomyopathy	0.00347	0.00866	CcSEcCtD
Eletriptan—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00345	0.00862	CcSEcCtD
Eletriptan—HTR7—heart—dilated cardiomyopathy	0.00336	0.0182	CbGeAlD
Eletriptan—PTGS1—myocardium—dilated cardiomyopathy	0.00333	0.018	CbGeAlD
Eletriptan—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00329	0.0082	CcSEcCtD
Eletriptan—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00327	0.00817	CcSEcCtD
Eletriptan—Thirst—Furosemide—dilated cardiomyopathy	0.00324	0.0081	CcSEcCtD
Eletriptan—Purpura—Furosemide—dilated cardiomyopathy	0.0032	0.008	CcSEcCtD
Eletriptan—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00319	0.00797	CcSEcCtD
Eletriptan—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00317	0.00792	CcSEcCtD
Eletriptan—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.0031	0.00774	CcSEcCtD
Eletriptan—Malaise—Spironolactone—dilated cardiomyopathy	0.00308	0.00769	CcSEcCtD
Eletriptan—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00306	0.00764	CcSEcCtD
Eletriptan—Photophobia—Lisinopril—dilated cardiomyopathy	0.003	0.00748	CcSEcCtD
Eletriptan—Neuropathy—Lisinopril—dilated cardiomyopathy	0.003	0.00748	CcSEcCtD
Eletriptan—Discomfort—Spironolactone—dilated cardiomyopathy	0.00287	0.00718	CcSEcCtD
Eletriptan—Confusional state—Spironolactone—dilated cardiomyopathy	0.00281	0.00702	CcSEcCtD
Eletriptan—Hypertonia—Lisinopril—dilated cardiomyopathy	0.0028	0.00698	CcSEcCtD
Eletriptan—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00278	0.00694	CcSEcCtD
Eletriptan—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00272	0.0068	CcSEcCtD
Eletriptan—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00269	0.00671	CcSEcCtD
Eletriptan—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00268	0.00668	CcSEcCtD
Eletriptan—Eczema—Lisinopril—dilated cardiomyopathy	0.00258	0.00643	CcSEcCtD
Eletriptan—CYP2C9—heart—dilated cardiomyopathy	0.00254	0.0138	CbGeAlD
Eletriptan—Injury—Lisinopril—dilated cardiomyopathy	0.00252	0.00629	CcSEcCtD
Eletriptan—Somnolence—Spironolactone—dilated cardiomyopathy	0.00248	0.00619	CcSEcCtD
Eletriptan—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00246	0.00615	CcSEcCtD
Eletriptan—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00244	0.0061	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00241	0.00601	CcSEcCtD
Eletriptan—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00241	0.00601	CcSEcCtD
Eletriptan—Arthritis—Lisinopril—dilated cardiomyopathy	0.00238	0.00595	CcSEcCtD
Eletriptan—Drowsiness—Furosemide—dilated cardiomyopathy	0.00238	0.00594	CcSEcCtD
Eletriptan—PTGS1—heart—dilated cardiomyopathy	0.00232	0.0126	CbGeAlD
Eletriptan—Diplopia—Lisinopril—dilated cardiomyopathy	0.00232	0.00578	CcSEcCtD
Eletriptan—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00232	0.00578	CcSEcCtD
Eletriptan—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0023	0.00574	CcSEcCtD
Eletriptan—Sweating—Furosemide—dilated cardiomyopathy	0.00228	0.00569	CcSEcCtD
Eletriptan—Face oedema—Lisinopril—dilated cardiomyopathy	0.00224	0.00558	CcSEcCtD
Eletriptan—Urticaria—Spironolactone—dilated cardiomyopathy	0.00222	0.00553	CcSEcCtD
Eletriptan—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0022	0.0055	CcSEcCtD
Eletriptan—Ataxia—Lisinopril—dilated cardiomyopathy	0.00218	0.00544	CcSEcCtD
Eletriptan—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00211	0.00527	CcSEcCtD
Eletriptan—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00209	0.00523	CcSEcCtD
Eletriptan—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00209	0.00521	CcSEcCtD
Eletriptan—Visual impairment—Furosemide—dilated cardiomyopathy	0.00206	0.00514	CcSEcCtD
Eletriptan—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00205	0.00513	CcSEcCtD
Eletriptan—Gastritis—Lisinopril—dilated cardiomyopathy	0.00205	0.00512	CcSEcCtD
Eletriptan—Influenza—Lisinopril—dilated cardiomyopathy	0.002	0.005	CcSEcCtD
Eletriptan—Asthma—Lisinopril—dilated cardiomyopathy	0.002	0.005	CcSEcCtD
Eletriptan—Tinnitus—Furosemide—dilated cardiomyopathy	0.00199	0.00497	CcSEcCtD
Eletriptan—PTGS1—cardiac atrium—dilated cardiomyopathy	0.00199	0.0108	CbGeAlD
Eletriptan—Pruritus—Spironolactone—dilated cardiomyopathy	0.00197	0.00493	CcSEcCtD
Eletriptan—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00195	0.00487	CcSEcCtD
Eletriptan—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00193	0.00482	CcSEcCtD
Eletriptan—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00193	0.00481	CcSEcCtD
Eletriptan—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00191	0.00476	CcSEcCtD
Eletriptan—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00191	0.00476	CcSEcCtD
Eletriptan—Dizziness—Spironolactone—dilated cardiomyopathy	0.00184	0.0046	CcSEcCtD
Eletriptan—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00184	0.0046	CcSEcCtD
Eletriptan—Flatulence—Furosemide—dilated cardiomyopathy	0.00183	0.00457	CcSEcCtD
Eletriptan—Weight increased—Lisinopril—dilated cardiomyopathy	0.00182	0.00455	CcSEcCtD
Eletriptan—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00182	0.00455	CcSEcCtD
Eletriptan—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00181	0.00452	CcSEcCtD
Eletriptan—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00181	0.00451	CcSEcCtD
Eletriptan—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00179	0.00446	CcSEcCtD
Eletriptan—Vomiting—Spironolactone—dilated cardiomyopathy	0.00177	0.00443	CcSEcCtD
Eletriptan—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00176	0.00439	CcSEcCtD
Eletriptan—Rash—Spironolactone—dilated cardiomyopathy	0.00176	0.00439	CcSEcCtD
Eletriptan—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00176	0.00439	CcSEcCtD
Eletriptan—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00175	0.00437	CcSEcCtD
Eletriptan—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00175	0.00437	CcSEcCtD
Eletriptan—Headache—Spironolactone—dilated cardiomyopathy	0.00175	0.00436	CcSEcCtD
Eletriptan—Anaemia—Furosemide—dilated cardiomyopathy	0.00172	0.00429	CcSEcCtD
Eletriptan—Sweating—Lisinopril—dilated cardiomyopathy	0.00171	0.00427	CcSEcCtD
Eletriptan—Agitation—Furosemide—dilated cardiomyopathy	0.00171	0.00427	CcSEcCtD
Eletriptan—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00168	0.0042	CcSEcCtD
Eletriptan—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00167	0.00418	CcSEcCtD
Eletriptan—Vertigo—Furosemide—dilated cardiomyopathy	0.00167	0.00417	CcSEcCtD
Eletriptan—Leukopenia—Furosemide—dilated cardiomyopathy	0.00166	0.00415	CcSEcCtD
Eletriptan—Nausea—Spironolactone—dilated cardiomyopathy	0.00166	0.00414	CcSEcCtD
Eletriptan—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00163	0.00407	CcSEcCtD
Eletriptan—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00161	0.00401	CcSEcCtD
Eletriptan—Hallucination—Lisinopril—dilated cardiomyopathy	0.00159	0.00398	CcSEcCtD
Eletriptan—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00159	0.00397	CcSEcCtD
Eletriptan—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00158	0.00395	CcSEcCtD
Eletriptan—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00158	0.00394	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00157	0.00392	CcSEcCtD
Eletriptan—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00157	0.00392	CcSEcCtD
Eletriptan—Dry mouth—Furosemide—dilated cardiomyopathy	0.00155	0.00386	CcSEcCtD
Eletriptan—Confusional state—Furosemide—dilated cardiomyopathy	0.00153	0.00382	CcSEcCtD
Eletriptan—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00149	0.00373	CcSEcCtD
Eletriptan—Shock—Furosemide—dilated cardiomyopathy	0.00149	0.00373	CcSEcCtD
Eletriptan—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00149	0.00371	CcSEcCtD
Eletriptan—Flushing—Lisinopril—dilated cardiomyopathy	0.00149	0.00371	CcSEcCtD
Eletriptan—Skin disorder—Furosemide—dilated cardiomyopathy	0.00147	0.00368	CcSEcCtD
Eletriptan—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00147	0.00366	CcSEcCtD
Eletriptan—Anorexia—Furosemide—dilated cardiomyopathy	0.00145	0.00361	CcSEcCtD
Eletriptan—Chills—Lisinopril—dilated cardiomyopathy	0.00144	0.00359	CcSEcCtD
Eletriptan—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00143	0.00357	CcSEcCtD
Eletriptan—Hypotension—Furosemide—dilated cardiomyopathy	0.00142	0.00354	CcSEcCtD
Eletriptan—Alopecia—Lisinopril—dilated cardiomyopathy	0.00142	0.00353	CcSEcCtD
Eletriptan—Flatulence—Lisinopril—dilated cardiomyopathy	0.00137	0.00343	CcSEcCtD
Eletriptan—ABCB1—heart—dilated cardiomyopathy	0.00137	0.00744	CbGeAlD
Eletriptan—Tension—Lisinopril—dilated cardiomyopathy	0.00137	0.00342	CcSEcCtD
Eletriptan—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00137	0.00341	CcSEcCtD
Eletriptan—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00136	0.0034	CcSEcCtD
Eletriptan—Nervousness—Lisinopril—dilated cardiomyopathy	0.00135	0.00338	CcSEcCtD
Eletriptan—Back pain—Lisinopril—dilated cardiomyopathy	0.00135	0.00337	CcSEcCtD
Eletriptan—Somnolence—Furosemide—dilated cardiomyopathy	0.00135	0.00337	CcSEcCtD
Eletriptan—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00134	0.00335	CcSEcCtD
Eletriptan—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00132	0.00329	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00131	0.00327	CcSEcCtD
Eletriptan—Fatigue—Furosemide—dilated cardiomyopathy	0.00131	0.00327	CcSEcCtD
Eletriptan—Tremor—Lisinopril—dilated cardiomyopathy	0.00131	0.00326	CcSEcCtD
Eletriptan—Pain—Furosemide—dilated cardiomyopathy	0.0013	0.00324	CcSEcCtD
Eletriptan—Constipation—Furosemide—dilated cardiomyopathy	0.0013	0.00324	CcSEcCtD
Eletriptan—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00129	0.00323	CcSEcCtD
Eletriptan—Anaemia—Lisinopril—dilated cardiomyopathy	0.00129	0.00322	CcSEcCtD
Eletriptan—Angioedema—Lisinopril—dilated cardiomyopathy	0.00127	0.00318	CcSEcCtD
Eletriptan—Malaise—Lisinopril—dilated cardiomyopathy	0.00126	0.00314	CcSEcCtD
Eletriptan—Vertigo—Lisinopril—dilated cardiomyopathy	0.00125	0.00313	CcSEcCtD
Eletriptan—Syncope—Lisinopril—dilated cardiomyopathy	0.00125	0.00312	CcSEcCtD
Eletriptan—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00125	0.00312	CcSEcCtD
Eletriptan—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00125	0.00312	CcSEcCtD
Eletriptan—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00124	0.0031	CcSEcCtD
Eletriptan—Palpitations—Lisinopril—dilated cardiomyopathy	0.00123	0.00308	CcSEcCtD
Eletriptan—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00123	0.00306	CcSEcCtD
Eletriptan—Cough—Lisinopril—dilated cardiomyopathy	0.00122	0.00304	CcSEcCtD
Eletriptan—Urticaria—Furosemide—dilated cardiomyopathy	0.00121	0.00301	CcSEcCtD
Eletriptan—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0012	0.00299	CcSEcCtD
Eletriptan—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0012	0.00299	CcSEcCtD
Eletriptan—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00119	0.00296	CcSEcCtD
Eletriptan—Myalgia—Lisinopril—dilated cardiomyopathy	0.00119	0.00296	CcSEcCtD
Eletriptan—Anxiety—Lisinopril—dilated cardiomyopathy	0.00118	0.00295	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00118	0.00294	CcSEcCtD
Eletriptan—Discomfort—Lisinopril—dilated cardiomyopathy	0.00117	0.00293	CcSEcCtD
Eletriptan—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00116	0.0029	CcSEcCtD
Eletriptan—Confusional state—Lisinopril—dilated cardiomyopathy	0.00115	0.00287	CcSEcCtD
Eletriptan—Oedema—Lisinopril—dilated cardiomyopathy	0.00114	0.00284	CcSEcCtD
Eletriptan—Shock—Lisinopril—dilated cardiomyopathy	0.00112	0.0028	CcSEcCtD
Eletriptan—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00112	0.00279	CcSEcCtD
Eletriptan—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00111	0.00277	CcSEcCtD
Eletriptan—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00111	0.00276	CcSEcCtD
Eletriptan—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.0011	0.00275	CcSEcCtD
Eletriptan—Asthenia—Furosemide—dilated cardiomyopathy	0.00109	0.00272	CcSEcCtD
Eletriptan—Anorexia—Lisinopril—dilated cardiomyopathy	0.00109	0.00271	CcSEcCtD
Eletriptan—Pruritus—Furosemide—dilated cardiomyopathy	0.00107	0.00268	CcSEcCtD
Eletriptan—Hypotension—Lisinopril—dilated cardiomyopathy	0.00106	0.00266	CcSEcCtD
Eletriptan—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00104	0.00259	CcSEcCtD
Eletriptan—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00104	0.00259	CcSEcCtD
Eletriptan—Insomnia—Lisinopril—dilated cardiomyopathy	0.00103	0.00257	CcSEcCtD
Eletriptan—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00102	0.00255	CcSEcCtD
Eletriptan—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00101	0.00253	CcSEcCtD
Eletriptan—Somnolence—Lisinopril—dilated cardiomyopathy	0.00101	0.00253	CcSEcCtD
Eletriptan—Dizziness—Furosemide—dilated cardiomyopathy	0.001	0.0025	CcSEcCtD
Eletriptan—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.001	0.0025	CcSEcCtD
Eletriptan—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00099	0.00247	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000983	0.00245	CcSEcCtD
Eletriptan—Fatigue—Lisinopril—dilated cardiomyopathy	0.000981	0.00245	CcSEcCtD
Eletriptan—Constipation—Lisinopril—dilated cardiomyopathy	0.000973	0.00243	CcSEcCtD
Eletriptan—Pain—Lisinopril—dilated cardiomyopathy	0.000973	0.00243	CcSEcCtD
Eletriptan—Vomiting—Furosemide—dilated cardiomyopathy	0.000965	0.00241	CcSEcCtD
Eletriptan—Rash—Furosemide—dilated cardiomyopathy	0.000957	0.00239	CcSEcCtD
Eletriptan—Dermatitis—Furosemide—dilated cardiomyopathy	0.000956	0.00239	CcSEcCtD
Eletriptan—Headache—Furosemide—dilated cardiomyopathy	0.00095	0.00237	CcSEcCtD
Eletriptan—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000938	0.00234	CcSEcCtD
Eletriptan—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.000931	0.00232	CcSEcCtD
Eletriptan—Urticaria—Lisinopril—dilated cardiomyopathy	0.000904	0.00226	CcSEcCtD
Eletriptan—Nausea—Furosemide—dilated cardiomyopathy	0.000901	0.00225	CcSEcCtD
Eletriptan—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.0009	0.00225	CcSEcCtD
Eletriptan—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.0009	0.00225	CcSEcCtD
Eletriptan—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000839	0.00209	CcSEcCtD
Eletriptan—Asthenia—Lisinopril—dilated cardiomyopathy	0.000817	0.00204	CcSEcCtD
Eletriptan—Pruritus—Lisinopril—dilated cardiomyopathy	0.000805	0.00201	CcSEcCtD
Eletriptan—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000779	0.00194	CcSEcCtD
Eletriptan—Dizziness—Lisinopril—dilated cardiomyopathy	0.000753	0.00188	CcSEcCtD
Eletriptan—Vomiting—Lisinopril—dilated cardiomyopathy	0.000724	0.00181	CcSEcCtD
Eletriptan—Rash—Lisinopril—dilated cardiomyopathy	0.000718	0.00179	CcSEcCtD
Eletriptan—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000717	0.00179	CcSEcCtD
Eletriptan—Headache—Lisinopril—dilated cardiomyopathy	0.000713	0.00178	CcSEcCtD
Eletriptan—Nausea—Lisinopril—dilated cardiomyopathy	0.000676	0.00169	CcSEcCtD
Eletriptan—HTR7—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000195	0.000986	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000193	0.00098	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000193	0.00098	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SDHA—dilated cardiomyopathy	0.000192	0.000973	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000189	0.00096	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000189	0.00096	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000189	0.000958	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000186	0.000945	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000186	0.000944	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000185	0.000938	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000185	0.000937	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000183	0.000926	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000181	0.000919	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000181	0.000919	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000181	0.000917	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00018	0.000911	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000178	0.000901	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000178	0.000901	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000177	0.000896	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000177	0.000896	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000176	0.000892	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000176	0.00089	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000176	0.00089	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000175	0.000888	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000174	0.000882	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000172	0.000873	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000172	0.000871	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000172	0.000871	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000171	0.000868	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000171	0.000864	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00017	0.000863	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000165	0.000838	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000164	0.000833	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000164	0.000829	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000163	0.000827	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000162	0.000822	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000162	0.000822	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000162	0.000821	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000162	0.000819	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000162	0.000819	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000162	0.000819	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00016	0.000812	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00016	0.00081	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000159	0.000807	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000158	0.000801	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000156	0.000792	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000156	0.000788	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000155	0.000785	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000154	0.000782	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000153	0.000776	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000153	0.000776	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000153	0.000776	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000151	0.000764	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00015	0.000761	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00015	0.000759	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000149	0.000754	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000149	0.000753	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000147	0.000744	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000146	0.00074	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000146	0.000738	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000145	0.000737	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000144	0.000731	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000144	0.000731	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000144	0.000728	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000144	0.000727	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000142	0.000721	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000142	0.00072	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000141	0.000715	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00014	0.00071	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000138	0.0007	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000138	0.0007	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000138	0.000698	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000138	0.000698	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000137	0.000693	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000136	0.000689	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000135	0.000684	CbGpPWpGaD
Eletriptan—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000134	0.000681	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000134	0.000681	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000134	0.00068	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000132	0.00067	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000131	0.000664	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000131	0.000664	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00013	0.000658	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00013	0.000658	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000129	0.000656	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000129	0.000654	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000128	0.000649	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000127	0.000642	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000126	0.00064	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000126	0.000636	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000125	0.000636	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000125	0.000632	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000124	0.000629	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000124	0.000628	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000122	0.000617	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000121	0.000611	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000119	0.000603	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000118	0.0006	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000118	0.000598	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000118	0.000598	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000118	0.000597	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000118	0.000596	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000118	0.000596	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000117	0.000593	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000117	0.000592	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000114	0.00058	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000114	0.000579	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000112	0.000566	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000111	0.000562	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00011	0.000559	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00011	0.000555	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000109	0.00055	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.000108	0.000546	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000107	0.000545	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000107	0.000543	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000107	0.000541	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000105	0.000534	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000105	0.000533	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000105	0.00053	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000104	0.000529	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000104	0.000529	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000104	0.000526	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000104	0.000526	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000103	0.000523	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000102	0.000519	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000102	0.000515	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000102	0.000515	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000102	0.000515	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000102	0.000515	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000101	0.000511	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000101	0.00051	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.0001	0.000507	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.95e-05	0.000504	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.74e-05	0.000494	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—RAF1—dilated cardiomyopathy	9.73e-05	0.000493	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.71e-05	0.000492	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.65e-05	0.000489	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.63e-05	0.000488	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	9.59e-05	0.000486	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—AGT—dilated cardiomyopathy	9.57e-05	0.000485	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	9.56e-05	0.000484	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.54e-05	0.000484	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.54e-05	0.000484	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—AGT—dilated cardiomyopathy	9.5e-05	0.000482	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CXCR3—dilated cardiomyopathy	9.44e-05	0.000479	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.4e-05	0.000476	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.34e-05	0.000473	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—AGT—dilated cardiomyopathy	9.31e-05	0.000472	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	9.19e-05	0.000466	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.15e-05	0.000464	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADRB1—dilated cardiomyopathy	9.15e-05	0.000464	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.87e-05	0.00045	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	8.78e-05	0.000445	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	8.74e-05	0.000443	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	8.72e-05	0.000442	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RAC1—dilated cardiomyopathy	8.67e-05	0.000439	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.59e-05	0.000435	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AGT—dilated cardiomyopathy	8.28e-05	0.00042	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.28e-05	0.00042	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	8.17e-05	0.000414	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGTR1—dilated cardiomyopathy	8.03e-05	0.000407	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.98e-05	0.000404	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.81e-05	0.000396	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	7.81e-05	0.000396	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.78e-05	0.000394	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	7.74e-05	0.000392	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	7.74e-05	0.000392	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.62e-05	0.000386	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.57e-05	0.000384	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	7.42e-05	0.000376	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.41e-05	0.000376	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.34e-05	0.000372	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	7.19e-05	0.000365	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.14e-05	0.000362	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—AGT—dilated cardiomyopathy	7.09e-05	0.000359	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.07e-05	0.000358	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.04e-05	0.000357	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.97e-05	0.000353	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.97e-05	0.000353	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.96e-05	0.000353	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.95e-05	0.000352	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—EGFR—dilated cardiomyopathy	6.67e-05	0.000338	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.64e-05	0.000336	CbGpPWpGaD
Eletriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	6.63e-05	0.000336	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.6e-05	0.000334	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.55e-05	0.000332	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	6.51e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.5e-05	0.00033	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.46e-05	0.000327	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.37e-05	0.000323	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	6.34e-05	0.000321	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.26e-05	0.000317	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	6.09e-05	0.000309	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.07e-05	0.000307	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.98e-05	0.000303	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.95e-05	0.000302	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RAC1—dilated cardiomyopathy	5.91e-05	0.0003	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RAC1—dilated cardiomyopathy	5.88e-05	0.000298	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.75e-05	0.000292	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RAF1—dilated cardiomyopathy	5.75e-05	0.000291	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	5.71e-05	0.000289	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AGT—dilated cardiomyopathy	5.65e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	5.65e-05	0.000286	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AGT—dilated cardiomyopathy	5.61e-05	0.000284	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	5.52e-05	0.00028	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AGT—dilated cardiomyopathy	5.5e-05	0.000279	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	5.4e-05	0.000274	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CD36—dilated cardiomyopathy	5.37e-05	0.000272	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GPX1—dilated cardiomyopathy	5.22e-05	0.000264	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	5.16e-05	0.000262	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CD36—dilated cardiomyopathy	5.08e-05	0.000257	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.92e-05	0.000249	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.85e-05	0.000246	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AGT—dilated cardiomyopathy	4.84e-05	0.000245	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AGT—dilated cardiomyopathy	4.57e-05	0.000232	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.55e-05	0.000231	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.52e-05	0.000229	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.43e-05	0.000224	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAC1—dilated cardiomyopathy	4.38e-05	0.000222	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AGT—dilated cardiomyopathy	4.19e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	4.18e-05	0.000212	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.16e-05	0.000211	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.03e-05	0.000204	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—EGFR—dilated cardiomyopathy	3.94e-05	0.0002	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RAF1—dilated cardiomyopathy	3.92e-05	0.000199	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RAF1—dilated cardiomyopathy	3.9e-05	0.000197	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.82e-05	0.000193	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	3.58e-05	0.000182	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	3.37e-05	0.000171	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	3.18e-05	0.000161	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.1e-05	0.000157	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	3.1e-05	0.000157	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.02e-05	0.000153	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.93e-05	0.000148	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RAF1—dilated cardiomyopathy	2.91e-05	0.000147	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	2.9e-05	0.000147	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.85e-05	0.000144	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	2.82e-05	0.000143	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	2.79e-05	0.000141	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGT—dilated cardiomyopathy	2.72e-05	0.000138	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—EGFR—dilated cardiomyopathy	2.69e-05	0.000136	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—EGFR—dilated cardiomyopathy	2.67e-05	0.000135	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.62e-05	0.000133	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.56e-05	0.00013	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.54e-05	0.000129	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	2.46e-05	0.000125	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—EGFR—dilated cardiomyopathy	1.99e-05	0.000101	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.91e-05	9.69e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.86e-05	9.44e-05	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.68e-05	8.5e-05	CbGpPWpGaD
